Literature DB >> 19845213

Cognitive impairment and mortality in the Cardiovascular Health Study.

Robert M Shavelle1, David R Paculdo, David J Strauss, Scott J Kush.   

Abstract

Cognitive impairment is associated with increased mortality, depending on the severity of impairment. We analyzed data from the Cardiovascular Health Study (CHS), using Cox proportional hazards regression models to quantify the effect of the impairment. After adjustment for age, sex, and medical risk factors, we found the resulting relative risks to range from 1.19 for mild impairment to 1.98 for severe.

Entities:  

Mesh:

Year:  2009        PMID: 19845213

Source DB:  PubMed          Journal:  J Insur Med        ISSN: 0743-6661


  5 in total

1.  Cognitive function and the risk of death in chronic kidney disease.

Authors:  Kalani L Raphael; Guo Wei; Tom Greene; Bradley C Baird; Srinivasan Beddhu
Journal:  Am J Nephrol       Date:  2011-12-21       Impact factor: 3.754

2.  Cognitive impairment and low physical activity are the components of frailty more strongly associated with disability.

Authors:  J A Ávila-Funes; S D Pina-Escudero; S Aguilar-Navarro; L M Gutierrez-Robledo; L Ruiz-Arregui; H Amieva
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Smoking, cognitive function and mortality in a U.S. national cohort study.

Authors:  Richard F Gillum; John Kwagyan; Thomas O Obisesan
Journal:  Int J Environ Res Public Health       Date:  2011-09-07       Impact factor: 3.390

Review 4.  Cognitive function in patients with coronary artery disease: A literature review.

Authors:  J Burkauskas; P Lang; A Bunevičius; J Neverauskas; M Bučiūtė-Jankauskienė; N Mickuvienė
Journal:  J Int Med Res       Date:  2018-08-29       Impact factor: 1.671

5.  Cognitive function and its transitions in predicting all-cause mortality among urban community-dwelling older adults.

Authors:  Mu-Cyun Wang; Tsai-Chung Li; Chia-Ing Li; Chiu-Shong Liu; Chih-Hsueh Lin; Wen-Yuan Lin; Chuan-Wei Yang; Shing-Yu Yang; Cheng-Chieh Lin
Journal:  BMC Psychiatry       Date:  2020-05-06       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.